Spirometry is necessary for the diagnosis and monitoring of both obstructive and restrictive lung diseases. Today, the most rapidly growing health problem in the United States is chronic obstructive pulmonary disease (COPD). COPD is now the fourth most common cause of death and the only cause of death that is rising among the top ten causes. There is also an increasing prevalence of interstitial lung diseases. Both obstructive and interstitial lung diseases are identified and monitored by spirometry.
Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159:179-187.
2.
Swanney MP, Jensen RL, Crichton DA, et al.FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med. 2000;162:917-919.
3.
Stanescu DC, Rodenstein DO, Hoeven C, et al."Sensitive tests" are poor predictors of the decline in forced expiratory volume in one second in middle-aged smokers. Am Reu Respir Dis. 1987; 135:585-590.
4.
Enright PL, Hyatt RE. Office Spirometry: A Practical Guide to the Selection and Use of Spirometers. Philadelphia, Pa: Lea & Febiger; 1987:253.
5.
Schoh RJ, Fero L, Shapiro H, et al.Performance of a new screening spirometer at a community health fair. Chest. In press.
6.
Eaton T, Withy S, Garrett JE, et al.Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116:416-423.
7.
Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA. 1997;277:246-253.
8.
Ferguson GT, Enright PL, Buist AS, et al.Office spirometry for lung health assessment in adults. A consensus statement from the National Lung Health Education Program. Chest. 2000;117: 1146-1161.
9.
Anthonisen NR, Connett JE, Kiley JP, et al.Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV,. The Lung Health Study. JAMA. 1994;272:1497-1505.
10.
Mannino DM, Gagnon RC, Petty TL, et al.Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160:1683-1689.
11.
Katzenstein AA, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301-1315.
12.
Selman M, King TE Jr, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136-151.
